Prestige Consumer Healthcare Inc. Cash And Cash Equivalents At Carrying Value

• Prestige Consumer Healthcare Inc. showed an increase of +110.6% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
• This data is from Prestige Consumer Healthcare Inc.'s annual report (Form 10-K), filed with the SEC on May 9, 2025.
• XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2010: $33.11 million | Q3 2010: $55.03 million | Q4 2010: $83.27 million | Q2 2011: $5.99 million | Q3 2011: $7.96 million | Q4 2011: $4.44 million | Q2 2012: $4.40 million | Q3 2012: $29.01 million | Q4 2012: $10.43 million | Q2 2013: $19.31 million | Q3 2013: $26.83 million | Q4 2013: $94.35 million | Q2 2014: $15.68 million | Q3 2014: $21.75 million | Q4 2014: $21.95 million | Q2 2015: $21.60 million | Q3 2015: $22.15 million | Q4 2015: $48.97 million | Q2 2016: $28.88 million | Q3 2016: $30.46 million | Q4 2016: $63.29 million | Q1 2017: $41.86 million | Q2 2017: $44.14 million | Q3 2017: $42.98 million | Q4 2017: $45.38 million | Q2 2018: $34.27 million | Q3 2018: $36.91 million | Q4 2018: $24.67 million | Q2 2019: $29.04 million | Q3 2019: $27.91 million | Q4 2019: $28.59 million | Q2 2020: $57.94 million | Q3 2020: $26.60 million | Q4 2020: $62.10 million | Q2 2021: $163.62 million | Q3 2021: $42.82 million | Q4 2021: $21.02 million | Q2 2022: $35.87 million | Q3 2022: $42.44 million | Q4 2022: $86.36 million | Q2 2023: $54.58 million | Q3 2023: $60.07 million | Q4 2023: $63.62 million | Q2 2024: $34.26 million | Q3 2024: $51.54 million | Q4 2024: $50.87 million | Q1 2025: $97.88 million | Q2 2025: $139.50 million | Q3 2025: $119.11 million | Q4 2025: $62.37 million.
• Over the full 17 years of available data (2009 to 2025), Prestige Consumer Healthcare Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 178.2%.
• Historical annual values: Fiscal year 2025: $97.88 million | Fiscal year 2024: $46.47 million | Fiscal year 2023: $58.49 million | Fiscal year 2022: $27.19 million | Fiscal year 2021: $32.30 million | Fiscal year 2020: $94.76 million | Fiscal year 2019: $27.53 million | Fiscal year 2018: $32.55 million | Fiscal year 2017: $41.86 million | Fiscal year 2016: $27.23 million | Fiscal year 2015: $21.32 million | Fiscal year 2014: $28.33 million | Fiscal year 2013: $15.67 million | Fiscal year 2012: $19.02 million | Fiscal year 2011: $13.33 million | Fiscal year 2010: $41.10 million | Fiscal year 2009: $35.18 million.
• Data sourced from SEC EDGAR public filings as of August 10, 2026.

Last verified: August 10, 2026